Compile Data Set for Download or QSAR
Report error Found 270 Enz. Inhib. hit(s) with Target = 'Serine/threonine-protein kinase MRCK alpha'
TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572232BDBM572232(3-[4-[(6S)-1,8-diazaspiro[5.5]undecan-8-yl]-1H- py...)
Affinity DataKi:  0.00500nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572231BDBM572231(US11447505, Example E236 | 3-[4-[(6S)-1,8-diazaspi...)
Affinity DataKi:  0.0120nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572233BDBM572233(US11447505, Example E168 | (6S)-8-(3-pyrimidin-4-y...)
Affinity DataKi:  0.0140nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572237BDBM572237(2-[4-[(5S)-2,6-diazaspiro[4.5]decan-2-yl]-1H- pyrr...)
Affinity DataKi:  0.0150nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572236BDBM572236((6S)-1-methyl-8-(3-pyrimidin-4-yl-1H-pyrrolo[2,3- ...)
Affinity DataKi:  0.0190nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572244BDBM572244(2-[4-[(5S)-2,6-diazaspiro[4.5]decan-2-yl]-1H- pyrr...)
Affinity DataKi:  0.0210nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572240BDBM572240((6S)-1-ethyl-8-(3-pyrimidin-4-yl-1H-pyrrolo[2,3- b...)
Affinity DataKi:  0.0280nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572282BDBM572282((6S)-8-(3-pyrimidin-5-yl-1H-pyrrolo[2,3-b]pyridin-...)
Affinity DataKi:  0.0280nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572249BDBM572249((5S)-2-(3-pyrimidin-4-yl-1H-pyrrolo[2,3-b]pyridin-...)
Affinity DataKi:  0.0320nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572234BDBM572234(2-[4-[(6S)-1,8-diazaspiro[5.5]undecan-8-yl]-1H- py...)
Affinity DataKi:  0.0330nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572243BDBM572243((5S)-2-(3-pyrimidin-5-yl-1H-pyrrolo[2,3-b]pyridin-...)
Affinity DataKi:  0.0410nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572239BDBM572239((6S)-8-[3-(2-pyridyl)-1H-pyrrolo[2,3-b]pyridin-4-y...)
Affinity DataKi:  0.0430nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572242BDBM572242(2-[4-[(6S)-1,8-diazaspiro[5.5]undecan-8-yl]-1H- py...)
Affinity DataKi:  0.0490nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572268BDBM572268(3-[4-(2,6-diazaspiro[4.5]decan-2-yl)-1H-pyrrolo[2,...)
Affinity DataKi:  0.0520nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572247BDBM572247(8-[3-(5-fluoro-3-pyridyl)-1H-pyrrolo[2,3-b]pyridin...)
Affinity DataKi:  0.0640nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572251BDBM572251(4-[4-(1,8-diazaspiro[5.5]undecan-8-yl)-1H-pyrrolo[...)
Affinity DataKi:  0.0680nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572253BDBM572253(3-ethyl-1-[3-(5-methylthiazol-2-yl)-1H-pyrrolo[2,3...)
Affinity DataKi:  0.0820nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572255BDBM572255(3-methyl-1-(3-thiazol-2-yl-1H-pyrrolo[2,3-b]pyridi...)
Affinity DataKi:  0.0930nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572231BDBM572231(US11447505, Example E236 | 3-[4-[(6S)-1,8-diazaspi...)
Affinity DataKi:  0.0950nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572238BDBM572238(2-[4-(1-ethyl-1,8-diazaspiro[5.5]undecan-8-yl)-1H-...)
Affinity DataKi:  0.101nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572246BDBM572246(2-[4-(1-ethyl-1,8-diazaspiro[5.5]undecan-8-yl)-1H-...)
Affinity DataKi:  0.127nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572308BDBM572308(8-(3-pyrazin-2-yl-1H- pyrrolo[2,3-b]pyridin-4-yl)-...)
Affinity DataKi:  0.131nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572274BDBM572274((3S)-N-methyl-1-(3-thiazol-2-yl-1H-pyrrolo[2,3- b]...)
Affinity DataKi:  0.158nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572257BDBM572257(8-[3-(5-fluoro-2-pyridyl)-1H-pyrrolo[2,3-b]pyridin...)
Affinity DataKi:  0.170nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572265BDBM572265(US11447505, Example E212)
Affinity DataKi:  0.185nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572258BDBM572258(8-[3-(3-fluoro-2-pyridyl)-1H-pyrrolo[2,3-b]pyridin...)
Affinity DataKi:  0.189nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572305BDBM572305(US11447505, Example E218)
Affinity DataKi:  0.189nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572273BDBM572273(2-[4-[(5S)-1,7-diazaspiro[4.4]nonan-7-yl]-1H- pyrr...)
Affinity DataKi:  0.190nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572259BDBM572259(3-[4-(1,7-diazaspiro[4.4]nonan-7-yl)-1H-pyrrolo[2,...)
Affinity DataKi:  0.207nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572267BDBM572267(3-[4-(1,8-diazaspiro[5.5]undecan-8-yl)-1H-pyrrolo[...)
Affinity DataKi:  0.216nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572294BDBM572294(9-(3-pyrimidin-5-yl-1H- pyrrolo[2,3-b]pyridin-4-yl...)
Affinity DataKi:  0.217nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572262BDBM572262((3S)-N-methyl-1-(3-pyrimidin-4-yl-1H-pyrrolo[2,3- ...)
Affinity DataKi:  0.238nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572263BDBM572263(4-[(6S)-1,8-diazaspiro[5.5]undecan-8-yl]-1H- pyrro...)
Affinity DataKi:  0.249nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572312BDBM572312(8-(3-pyridazin-3-yl-1H- pyrrolo[2,3-b]pyridin-4-yl...)
Affinity DataKi:  0.257nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572285BDBM572285((3S)-N-methyl-1-(3- pyridazin-4-yl-1H- pyrrolo[2,3...)
Affinity DataKi:  0.274nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572270BDBM572270((3S)-N-cyclopropyl-1-(3-pyridazin-4-yl-1H-pyrrolo[...)
Affinity DataKi:  0.322nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572302BDBM572302(N-methyl-1-(3-pyrimidin- 5-yl-1H-pyrrolo[2,3- b]py...)
Affinity DataKi:  0.382nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572320BDBM572320((3S)-N-methyl-1-[3-(1H- pyrazol-3-yl)-1H- pyrrolo[...)
Affinity DataKi:  0.481nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572279BDBM572279(US11447505, Example E184)
Affinity DataKi:  0.481nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572264BDBM572264(3-methyl-1-(3-pyrimidin-5-yl-1H-pyrrolo[2,3-b]pyri...)
Affinity DataKi:  0.517nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572343BDBM572343((3S)-N-methyl-1-[3-(1H- pyrazol-4-yl)-1H- pyrrolo[...)
Affinity DataKi:  0.522nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572321BDBM572321((3S)-N-methyl-1-(3- pyridazin-3-yl-1H- pyrrolo[2,3...)
Affinity DataKi:  0.566nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572313BDBM572313(US11447505, Example E188)
Affinity DataKi:  0.598nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572336BDBM572336((3S)-N-methyl-1-(3- pyrazin-2-yl-1H- pyrrolo[2,3-b...)
Affinity DataKi:  0.629nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572276BDBM572276(4-(1-ethyl-1,8-diazaspiro[5.5]undecan-8-yl)-1H- py...)
Affinity DataKi:  0.631nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572332BDBM572332(2-(3-pyrimidin-5-yl-1H- pyrrolo[2,3-b]pyridin-4-yl...)
Affinity DataKi:  0.652nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572342BDBM572342((3S)-N-cyclopropyl-1-(3- pyrimidin-5-yl-1H- pyrrol...)
Affinity DataKi:  0.935nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 2579BDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 0.998nMAssay Description:Inhibition of human MRCKalpha using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572303BDBM572303(5-[4-(1-piperidyl)-1H- pyrrolo[2,3-b]pyridin-3- yl...)
Affinity DataKi:  1.11nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase MRCK alpha(Human)
Cancer Research Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 572317BDBM572317(4-(azepan-4-yloxy)-3- pyrimidin-5-yl-1H- pyrrolo[2...)
Affinity DataKi:  1.13nMAssay Description:MRCKα, MRCKβ, ROCK1 and ROCK2 assays were performed using an IMAP fluorescence polarization assay format (Molecular Devices Inc.). 8-12 nM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2022
Entry Details
US Patent

Displayed 1 to 50 (of 270 total ) | Next | Last >>
Jump to: